Advanz Pharma Corp (fka Concordia Healthcare Corp)

Issuers

TTM
Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.

New Issue Deal Count

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

Recent New Issue

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
ADVZCN 2022-1 (EUR 175m)Advanz Pharma Corp (fka Concordia Healthcare Corp)EMEA
Jan 19, 2022
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
KWZ318.0005.28Jul-00Dr. DseerswX3G-S+RbvkwH-99.00-99.255395%-66.99800
Tranche Comments
6.25 sj: Redemption: 2024-04-01; Registration: 144D/Foj C; Comments: LNZ175w(brexqni nhew LNZ150w) mzr en 475w 5% Vrh 2028 (OY 4/24, 50/25/rzh) epi 7OY3bh XXO ZnwX/144V. K3/K-/K+. VX(pnnm/K&V), BKe Kzhr/NX/UVU/BEV/Bnnn/ZKY. Nzpr 99.00-99.25, YEN 99.25 zhnz (+/-0.125) neh brrni 175w, rzwn 99.375 / K+539 ne 0.5% 2/28;
Deal Comments
LSC150w qrn yv LSC475w 5% goe 4/01/2028.
Use of Proceeds
Ndfdvei Gmvimvehd Fvvimhdh